(MedPage Today) — Treatment with investigational duvakitug appeared to improve remission rates among patients with ulcerative colitis and endoscopic response rates in those with Crohn's disease, results from two cohorts of the phase IIb RELIEVE…
Source: MedPage Today — Headlines
